← Leaderboards
David Fran Stroncek
Clinical Center
$454,987
Attributed
$1,364,962
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $448.2K · FY2018–21$500K$375K$250K$125K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$1,364,962 · 1
By mechanism
U01$1,364,962 · 1
Top collaborators
- Catherine C Hedrick4 shared
- Rosandra Kaplan4 shared
Most similar at Clinical Center
Same institution · by research overlap
Others in their field
Other Emerging Leaders on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Kevin Urdahl · Seattle Children'S Hospital$72,239,698
- Martha Hering · Westat, Inc.$57,098,843
- Leonard Freedman · Leidos Biomedical Research, Inc.$34,953,667
- Thomas Denny · Duke University$23,095,705
Research focus
Human SubjectClinical ResearchBlood DonorImmunotherapyNeutrophilHematopoietic Stem CellsLeukocytesBloodErythrocytesColony Stimulating FactorCellsGranulocyteGenetic PolymorphismSourceCytomegalovirusPatient Oriented ResearchCell Population StudySickle Cell AnemiaGene ExpressionDexamethasoneMethod DevelopmentCitratesImmuneBlood Chemistry
Grant awards (42)
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$136,148
U01 · FY2021 · CA
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$448,200
U01 · FY2020 · CA
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$362,294
U01 · FY2019 · CA
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$418,320
U01 · FY2018 · CA
Structure and Function Granulocyte Antigens$39,364
Z01 · FY2008 · CL · contact PI
RBC Leukocyte Reduction Filter Failures in Blood Donors With Sickle Trait$39,364
Z01 · FY2008 · CL · contact PI
Immune Therapy For Cytomegalovirus Infection$39,364
Z01 · FY2008 · CL · contact PI
The use of Hematopoietic Growth Factors in Healthy Subjects$39,364
Z01 · FY2008 · CL · contact PI
The use of Hematopoietic Growth Factors in Healthy Subjects$41,216
Z01 · FY2007 · CL · contact PI
RBC Leukocyte Reduction Filter Failures in Blood Donors With Sickle Trait$41,216
Z01 · FY2007 · CL · contact PI
Immune Therapy For Cytomegalovirus Infection$41,216
Z01 · FY2007 · CL · contact PI
Structure and Function Granulocyte Antigens$41,216
Z01 · FY2007 · CL · contact PI
The use of Granulocyte Colony-Stimulating-Factor in Heal$0
Z01 · FY2006 · CL · contact PI
RBC Leukocyte Reduction Filter Failures in Blood Donors$0
Z01 · FY2006 · CL · contact PI
Immune Therapy For Cytomegalovirus Infection$0
Z01 · FY2006 · CL · contact PI
Structure and Function of Granulocyte Antigens$0
Z01 · FY2006 · CL · contact PI
Immune Therapy For Cytomegalovirus Infection$0
Z01 · FY2005 · CL
RBC Leukocyte Reduction Filter Failures in Blood Donors$0
Z01 · FY2005 · CL
Structure and Function of Granulocyte Antigens$0
Z01 · FY2005 · CL
Granulocyte Colony-Stimulating Factor in Healthy Donors$0
Z01 · FY2005 · CL
Leukocyte Reduction Filter Blood Donor Sickle Cell Trait$0
Z01 · FY2004 · CL
Structure Function of Granulocyte Antigens$0
Z01 · FY2004 · CL
Granulocyte Colony-Stimulating-Factor in Healthy Donors$0
Z01 · FY2004 · CL
Immune Therapy For Cytomegalovirus Infection$0
Z01 · FY2004 · CL
Immune Therapy For Cytomegalovirus Infection$0
Z01 · FY2003 · CL
The use of Granulocyte Colony-Stimulating-Factor in Heal$0
Z01 · FY2003 · CL
Structure and Function of Granulocyte Antigens$0
Z01 · FY2003 · CL
RBC Leukocyte Reduction Filter Failures in Blood Donors$0
Z01 · FY2003 · CL
The use of Granulocyte Colony-Stimulating-Factor in Heal$0
Z01 · FY2002 · CL
Structure and Function of Granulocyte Antigens$0
Z01 · FY2002 · CL
Dissecting the Molecular Immunology of T Cell-Aimed Vacc$0
Z01 · FY2002 · CL
RBC Leukocyte Reduction Filter Failures in Blood Donors$0
Z01 · FY2002 · CL
Immune Therapy For Cytomegalovirus Infection$0
Z01 · FY2002 · CL
Malarial Anemia$0
Z01 · FY2002 · CL
Rbc Leukocyte Reduction Filter Failures In Blood Donors$0
Z01 · FY2001 · CL
Effects of Granulocyte Colony-stimulating Factor on Granulocyte Donors$0
Z01 · FY2000 · CL
ADOPTIVE IMMUNE THERAPY FOR CYTOMEGALOVIRUS INFECTION$0
Z01 · FY2000 · CL
MALARIAL ANEMIA$0
Z01 · FY2000 · CL
Kinetics of Granulocyte Colony-stimulating-factor-induced Granulocyte Mobilizati$0
Z01 · FY2000 · CL
Storage of Granulocyte Concentrates$0
Z01 · FY2000 · CL
Structure and Function of Granulocyte Antigens$0
Z01 · FY2000 · CL
DISSECTING THE MOLECULAR IMMUNOLOGY OF T-CELL-AIMED VACC$0
Z01 · FY2000 · CL